Press Releases
 
Antiepileptic Drugs Market : Global Segments, Top Key Players, Size and Recent Trends by Forecast to

, 12 October 2018 -- The market for antiepileptic drugs is broadly classified on the basis of first generation antiepileptic drugs and second generation antiepileptic drugs and pipeline drugs.

Antiepileptic drugs are therapies approved to treat patients with epilepsy, a brain disorder in which clusters of nerve cells signal abnormally, which can lead to seizures. These seizures are incidents that occur when group of nerve cells or neurons in brain sends wrong signals. Patients suffering from epilepsy may complain about strange emotions and sensations or they may behave strangely. Epilepsy is the fourth most common brain disorder affecting people of all ages. The causes of epilepsy are undetermined however major risk factors involved include brain injury, brain tumor, stroke, and substance use disorders. For the treatment of epilepsy, antiepileptic medicines (AEDs) are prescribed, preference of the drug depending on the age of the patient, type of seizures to be treated, seriousness of the seizures, and part of the brain involved. Alcoholism, smoking, changing lifestyle and rising geriatric population are the major factor driving the antiepileptic market.
Read Report Overview: https://www.transparencymarketresearch.com/antiepileptic-drugs-market.html
The market for antiepileptic drugs is broadly classified on the basis of first generation antiepileptic drugs and second generation antiepileptic drugs and pipeline drugs. First generation antiepileptic drugs consists of Valproate (Depakote), Oxycarbazepine ((Trileptal), Carbamazepine (Carbatrol), Phenobarbital (Luminal), Primidone (Mysoline), Ethosuximide (Zarontin), Topiramate (Topamax) Phenytoin (Dilantin, Phenytek). Second generation antiepileptic drugs consist of different mechanism of action than the first generation drugs. These consists of Lamotrigine (Lamictal), Pregabalin (Lyrica), Eslicarbazepine acetate Zonisamide (Zonegran), Lacosamide (Vimpat), Levetiracetam (Keppra), (Aptiom/Zebinix), Perampanel (Fycompa), Rufinamide (Banzel/Inovelon), Ezogabine/retigabine (Trobalt/Potiga),. First generation antiepileptic drugs majorly carbamazepine, valproate, phenytoin and oxycarbazepine are dominating the epilepsy therapeutics market. However, second generation AEDs such as levetiracetam, zonisamide and lacosamide are slowly overtaking the antiepileptic drugs market due to its improved tolerability and efficacy.
The pipeline for antiepileptic drugs has been segmented on different phases. The drugs in the phase III of the pipeline include Brivaracetam (UCB Pharma Ltd), Ganaxolone (Marinus Pharmaceuticals), USL261 (Upsher Smith Laboratories, Inc.), Perampanel (Eisai Co) and YKP3089 (SK Life Sciences) and others. The phase I and II of the pipeline drugs include Buspirone, Everoline, UCB0942 (PPSI), Lacosamide, GWP42006, TAK-932 and others. All this drugs are currently under clinical trials and it is expected that these drugs will prove beneficial for epilepsy therapeutics market.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7664
Geographically, North America dominates the global antiepileptic drugs market followed by Europe majorly due to the extensive research and development activities in the neurology and the presence of pharmaceutical industries in the region. Epilepsy affects approximately 2.5 million people in the United States, and results in an estimated annual cost of approximately $15.5 billion in healthcare. Three new antiepileptic drugs have been approved in U.S. since 2012 including ezogabine/retigabine, perampanel and eslicarbazepine acetate. Continuous increase in uptake of second generation antiepileptic drugs is also driving the antiepileptic drugs market in North America and Europe. Asia-Pacific is also increasing constantly in the antiepileptic drugs market mainly due to the high prevalence of epilepsy in India and China, increased penetration due to better market access options in China and expected approval of drugs with novel mechanisms are some of the factors responsible for expanding the epilepsy therapeutics market in the Asia-Pacific region. Latin America is also a growing market for antiepileptic drugs due to developing healthcare expenditure and high prevalence rate of epilepsy in the region.
Some of the major players in epilepsy therapeutics market include Abbott Laboratories, Cephalon, Inc, GlaxoSmithKline plc,., Johnson & Johnson, Novartis AG, Pfizer, Inc., Sunovion Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Sanofi S.A. and UCB Pharma Ltd.
Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=7664
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com/

# # #


Submitted by Sandy Researcher, Transparency Market Research on Friday, 12 October 2018 at 10:14 PM
Category: Health Care & Medical
 
Related News

Tips on Finding a fantastic Family Dentist
Saturday, 20 Oct 2018

Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific
Friday, 19 Oct 2018

Expert Sports Podiatrist, Mark Lin from Footwork Podiatry Sydney CBD and North Shore, Comments on Re
Friday, 19 Oct 2018

Solve.Care is presenting its healthcare on blockchain solution at the biggest healthcare conference
Friday, 19 Oct 2018

Pompe Disease Market 2016 - 2024: End Users, Region, Growth Rate and Sales
Thursday, 18 Oct 2018

Related Events

Abu Dhabi International Mental Health Conference, 2018
Friday, 19 Oct 2018

2018 Psychopharmacology Update
Saturday, 20 Oct 2018

Hepatitis B&C CME Training Program and Treatment Update, Sacramento, CA
Saturday, 20 Oct 2018

Hepatitis BandC CME Training Program and Treatment Update, Irvine, CA
Saturday, 20 Oct 2018

OmniaMed Kongress-Highlights Diabetologie Koln 2018
Saturday, 20 Oct 2018

Latest News

Tips on Finding a fantastic Family Dentist
Saturday, 20 Oct 2018

Forever Stands the Dependable Source for The Best Quality Induction Heat Treatment Equipment
Saturday, 20 Oct 2018

Document Translation Services, Software Localization & Testing
Saturday, 20 Oct 2018

Infographic revealing 5 Ways to Boost Your Digital Marketing Efforts by Using Infographics
Saturday, 20 Oct 2018

Disney to rename African Princess due to copyright dispute over African Animation film titled The Se
Saturday, 20 Oct 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Saturday, 20 October 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Marketing Strategy for Growth
  • Abu Dhabi International Mental Health Conference, 2018
  • Hepatitis B&C CME Training Program and Treatment Update, Sacramento, CA
  • Hepatitis BandC CME Training Program and Treatment Update, Irvine, CA
  • 2018 Psychopharmacology Update

  • Latest Jobs
    Sorry, there are currently no entries posted here.